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`    Experimental design
1.   Sample size
Describe how sample size was determined. No statistics to determine sample size were used. Sample size is similar to recent papers in 
behavioural neuroscience.
2.   Data exclusions
Describe any data exclusions. All data were included with verified virus expression
3.   Replication
Describe the measures taken to verify the reproducibility 
of the experimental findings.
Key surgeries, behavioral and histological assays were replicated by more than two lab 
members.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
No statistical randomization methods were used. However, mice used for data collection 
were both males and females, at least 8 weeks of age
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
The investigators were not blinded during data collection.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present 
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
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`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Custom MATLAB(2016 a) code, GraphPad Prism 7.02, ImageJ 1.50b, Leica LAS X and Microsoft 
Excel 2016 were used to analyze data. Code is 
available from the corresponding author upon reasonable request.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a third party.
No restrictions are placed on the availability of materials used. Some transgenic strains may 
be obtained from the original authors
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
The primary antibodies (1:500 dilution) used were - goat anti-c-Fos (Santa Cruz, SC-52G, Lot 
#I0216), rabbit anti-NOS1 (Santa Cruz, sc-648, Lot #K2415), rabbit anti-GAD65+GAD67 
(Abcam, ab183999, Lot #GR260178-2 ), chicken anti-GFP (Abcam, ab13970, Lot 
#GR236651-18) and rat anti-mCherry (Thermo Fisher, M11217,Lot #SF251482).
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. No eukaryotic cell lines were used.
b.  Describe the method of cell line authentication used. N/A
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
N/A
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
N/A
`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide all relevant details on animals and/or 
animal-derived materials used in the study.
Details of mice used for this study are given in the Methods section of the manuscript. 
The following mice  from the Jackson Laboratory were used (C57BL/6J; stock number 000664, 
Slc32a1 (Vgat)-Cre; stock number 016962, Ai9; stock number 007909, Ai3; stock number 
007903). 
GLP1r-Cre and Ai110 were generously provided by Fiona Gribble (Cambridge) and David 
Anderson (Caltech), respectively. 
At least 8 weeks of age of both male and female mice were used for this study. 
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
The study did not involve any human research participants.
